학술논문

Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial
Document Type
Article
Source
In The Lancet Oncology February 2024 25(2):184-197
Subject
Primary Research
Articles
Language
ISSN
1470-2045